Document is current

Any future updates will be listed below

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach

Crossref DOI link: https://doi.org/10.1186/s12885-024-12287-6

Published Online: 2024-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark